NALIRIFOX: clinical trials recruiting now
3
Recruiting trials
5
Conditions studied
3
US states with sites
1
Countries
Phase breakdown
Phase 1 3
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Pancreatic Cancer · NALIRIFOX for Pancreatic Cancer | 3 |
| Basal Cell Neoplasm | 1 |
| Metastatic Pancreatic Cancer | 1 |
| Pancreatic Adenocarcinoma | 1 |
| Pancreatic Ductal Adenocarcinoma (PDAC) | 1 |
Recruiting trials involving NALIRIFOX
- Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
- Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
Common questions
How many recruiting trials involve NALIRIFOX?
3 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.